CLVT.NYSEClarivate PLC

DEF: Clarivate PLC Sets 2026 AGM, Reports Mixed 2025 Financials

Sentiment:

Proxy Statement


Clarivate PLC announced its 2026 Annual General Meeting agenda, including director re-elections and executive compensation approval, alongside a review of its 2025 financial performance which saw revenue decline but net loss improve.

Worse than expectedRevenues decreased from $2.557 billion in 2024 to $2.455 billion in 2025.Adjusted net income decreased from $525 million in 2024 to $468 million in 2025.Adjusted EBITDA decreased from $1.060 billion in 2024 to $1.002 billion in 2025.Adjusted diluted EPS decreased from $0.73 in 2024 to $0.69 in 2025.Market capitalization significantly declined from $3.500 billion in 2024 to $2.100 billion in 2025.The 2023-2025 Performance Share Unit (PSU) awards achieved only 32.5% of target, indicating significant underperformance against long-term goals, including a Total Shareholder Return (TSR) modifier that was below the 25th percentile of the S&P 500.

Summary

  • The Annual General Meeting (AGM) is scheduled for Thursday, May 14, 2026, at the Clarivate corporate headquarters in London.
  • Shareholders will vote on the re-election of ten directors, an advisory, non-binding resolution to approve 2025 executive compensation, and the reappointment of PricewaterhouseCoopers LLP as auditors for fiscal year 2026.
  • Revenues for 2025 decreased to $2.455 billion from $2.557 billion in 2024.
  • The net loss significantly improved to $(201) million in 2025 from $(637) million in 2024.
  • Adjusted EBITDA declined to $1.002 billion in 2025 from $1.060 billion in 2024.
  • Free cash flow increased to $365 million in 2025 from $358 million in 2024.
  • Organic annualized contract value (ACV) growth accelerated to 1.8% in 2025, up from 0.9% in 2024.
  • The company launched new AI-powered products and features across its Academia & Government, Intellectual Property, and Life Sciences & Healthcare segments.
  • Executive compensation for 2025 saw the CEO receive 102% of target Annual Incentive Plan (AIP), while other Named Executive Officers (NEOs) ranged from 85% to 109% of target.
  • 2023-2025 Performance Share Unit (PSU) awards achieved only 32.5% of target after performance and Total Shareholder Return (TSR) modifier adjustments.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing with a cautious sentiment. While there are improvements in net loss and ACV growth, the overall decline in revenue, adjusted profitability metrics, and significant drop in market capitalization indicate underlying challenges despite strategic initiatives and strong governance.

Positives

  • Net income (loss) significantly improved from $(637) million in 2024 to $(201) million in 2025.
  • Net loss margin improved from (25)% in 2024 to (8)% in 2025.
  • Diluted EPS improved from $(0.96) in 2024 to $(0.30) in 2025.
  • Organic annualized contract value (ACV) growth accelerated to 1.8% in 2025, up from 0.9% in 2024.
  • Free cash flow increased to $365 million in 2025 from $358 million in 2024.
  • Successful launch of new AI-powered products and features across all segments, including Web of Science, ProQuest, Alma, RiskMark, Cortellis, and Derwent Patent Monitor.
  • Optimized business model by transitioning three product groups to a subscription approach.
  • Expanded customer base and relationships with notable organizations such as the British Library, Nissan, and Sinopec.
  • Strong shareholder support for executive compensation programs, with approximately 99% approval at the 2025 annual general meeting of shareholders.
  • Robust corporate governance practices, including an independent Board Chair, fully independent committees, and annual director elections.

Negatives

  • Revenues decreased to $2.455 billion in 2025 from $2.557 billion in 2024.
  • Adjusted net income decreased to $468 million in 2025 from $525 million in 2024.
  • Adjusted EBITDA decreased to $1.002 billion in 2025 from $1.060 billion in 2024.
  • Adjusted EBITDA margin decreased from 42% in 2024 to 41% in 2025.
  • Adjusted diluted EPS decreased to $0.69 in 2025 from $0.73 in 2024.
  • Net cash provided by operating activities decreased to $629 million in 2025 from $647 million in 2024.
  • Market capitalization significantly decreased to $2.100 billion in 2025 from $3.500 billion in 2024.
  • The Intellectual Property (IP) segment's Annual Incentive Plan (AIP) goals achieved only 48% weighted average attainment in 2025.
  • 2023-2025 Performance Share Unit (PSU) awards achieved only 32.5% of target, significantly below the 100% target, partly due to Total Shareholder Return (TSR) performance being less than the 25th percentile of the S&P 500.

Risks

  • Forward-looking statements involve risks and uncertainties that may cause actual results or performance to be materially different from those expressed or implied.
  • These risks and uncertainties include, but are not limited to, factors described under the caption 'Risk Factors' in the company's Annual Report.
  • The Human Resources and Compensation Committee assesses risks arising from compensation policies and practices, and an independent risk assessment determined they are not reasonably likely to have a material adverse effect on the business.

Future Outlook

The company aims to continue accelerating innovation by launching new products and features, optimizing its business model by transitioning more product groups to a subscription approach, serving new customers, expanding existing relationships, driving internal cost efficiencies, and focusing capital allocation on debt reduction and share repurchases to improve shareholder value. The next advisory, non-binding vote regarding the frequency of executive compensation approval will occur at the 2027 annual general meeting of shareholders.

Management Comments

  • "On behalf of our Board of Directors, I am pleased to invite you to the 2026 Annual General Meeting of Shareholders of Clarivate Plc." Andy Snyder, Chair of the Board
  • "Your participation is important, so please review these materials carefully and submit your voting instructions. Thank you for your continued support of Clarivate." Andy Snyder, Chair of the Board
  • "We believe that attracting and retaining superior talent and rewarding performance are key to delivering long-term shareholder returns, and that a competitive compensation program is critical to that end." Human Resources and Compensation Committee
  • "Our compensation programs continue to be a key driver of shareholder value creation, with a strong emphasis on variable/at-risk compensation as opposed to fixed compensation." Human Resources and Compensation Committee
  • "We believe our CEO pay ratio is a reasonable estimate calculated in a manner consistent with Item 402(u) of Regulation S-K." Company statement on CEO Pay Ratio

Industry Context

StockSavvy.ai notes that Clarivate's strategic focus on AI-powered solutions and transitioning to a subscription-based model aligns with broader industry trends in the information services and technology sectors, where digital transformation and recurring revenue streams are key drivers of growth and valuation. The company's efforts to expand its customer base and drive cost efficiencies are critical in a competitive landscape characterized by evolving technological demands and the need for sustained innovation. The decline in market capitalization, despite some operational improvements, suggests that the market may be re-evaluating valuations in the sector or reacting to broader economic pressures.

Comparison to Industry Standards

  • Clarivate's 2023-2025 three-year Total Shareholder Return (TSR) performance was less than the 25th percentile of the S&P 500, indicating underperformance relative to the broader market index.
  • The company's compensation benchmarking peer group for 2025 includes companies such as ACI Worldwide, Inc., Dun & Bradstreet Holdings, Inc., Equifax, Inc., FactSet Research Systems Inc., Gartner, Inc., and Verisk Analytics, Inc., suggesting it aims to align executive pay with similar-sized intelligence, data analytics, and digital delivery firms.
  • The 99% shareholder approval rate for executive compensation at the 2025 AGM suggests strong internal alignment with current compensation practices, contrasting with the underperformance of PSU awards tied to TSR relative to the S&P 500.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
DirectorMichael AngelakisNA2025-05-07Retirement from the Board.
DirectorNAKenneth Cornick2025-07-22Elected to the Board.
President, Intellectual PropertyGordon SamsonMaroun Mourad2025-09-08Gordon Samson ceased to be an executive officer on September 7, 2025, and Maroun Mourad commenced employment as President, Intellectual Property on September 8, 2025.
Executive Vice President and Chief Administrative and Legal OfficerMelanie MargolinNA2025-02-28Melanie Margolin ceased to be an executive officer on February 28, 2025, and departed the company on March 21, 2025.
DirectorValeria AlberolaNA2025-12-31Resignation from the Board.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment

Legal Proceedings

  • The filing mentions "legal settlements" as an adjustment in the calculation of Adjusted EBITDA and Adjusted net income, but provides no specific details on any ongoing or past legal proceedings.

Related Party Transactions

  • Clarivate assumed a finance lease from Cambridge Information Group (CIG), where Andrew Snyder (Board Chair) serves as CEO. In 2025, Clarivate recognized $2.0 million in interest expense and $0.5 million in amortization expense related to this lease.
  • CIG is a subtenant for certain office space leased by Clarivate, paying a monthly subtenancy fee of $22,000.
  • Customer and vendor arrangements exist with an affiliate of CIG, resulting in $0.5 million in revenues and $4.9 million in expenses for Clarivate in 2025.
  • Customer and vendor arrangements exist with an affiliate of Exor N.V. (Suzanne Heywood is COO of Exor), resulting in $3.0 million in revenues and $3.8 million in expenses for Clarivate in 2025.
  • Clarivate agreed to reimburse CIG's tax adviser up to $0.4 million for providing historical tax information related to an IRS examination of ProQuest's tax returns.
  • An Investment Agreement with Exor N.V. (March 4, 2024) grants Exor the right to nominate a director (Ms. Heywood) to the Board.
  • An Investor Rights Agreement (October 1, 2020) grants affiliates of Leonard Green & Partners, L.P. (LGP) the right to nominate directors (Mr. Cortas and Mr. Levyn) based on their ownership stake.

Stakeholder Impact

  • Shareholders will vote on key governance matters (director re-election, executive compensation, auditor appointment). Financial performance (decreased revenue, adjusted profit, market cap, but improved net loss and ACV growth) directly impacts shareholder value. The low payout on PSUs due to underperformance against long-term goals and TSR relative to the S&P 500 directly affects executive incentives tied to shareholder returns.
  • Employees: The Annual Incentive Plan (AIP) provides cash incentives to approximately 85% of employees, linking their performance to corporate goals. Executive compensation policies, including share ownership guidelines and clawbacks, aim to align executive interests with long-term company success.
  • Customers: The company's focus on accelerating innovation, launching new AI-powered products, and optimizing its business model aims to enhance customer experience and value. The "Voice of Customer" metric is a key component of the AIP, indicating a focus on customer loyalty and satisfaction.
  • Creditors: Capital allocation strategies focusing on debt reduction are positive for creditors. The finance lease liability of $28.1 million is noted as indebtedness.

Next Steps

  • Hold the 2026 Annual General Meeting of Shareholders on May 14, 2026.
  • Shareholders to vote on director re-elections, advisory approval of executive compensation, and auditor reappointment.
  • Final voting results of the Annual Meeting to be disclosed in a Current Report on Form 8-K within four business days following the meeting.
  • The Board and Audit Committee will reconsider retaining PwC if shareholders do not ratify their selection.
  • The Human Resources and Compensation Committee will evaluate actions if there is a significant vote against Named Executive Officer (NEO) compensation policies.
  • The next advisory, non-binding vote regarding the frequency of executive compensation approval will occur at the 2027 annual general meeting of shareholders.

Key Dates

DateDescription
2019-05Anthony Munk became a director.
2020-05Jane Okun Bomba became a director.
2020-10Usama N. Cortas and Adam T. Levyn became directors.
2020-10-01Clarivate entered into an Investor Rights Agreement in connection with the acquisition of CPA Global.
2020-10Anthony Munk served as Lead Independent Director from May 2020 to October 2022.
2021-01-01Fiscal year 2021 began.
2021-12Andrew Snyder became a director.
2021-12-01Clarivate completed the acquisition of ProQuest from CIG.
2021-12-01Clarivate entered into an amendment to its existing Registration Rights Agreement.
2021-12-31Fiscal year 2021 ended.
2022-01-01Fiscal year 2022 began.
2022-02William Graff joined Clarivate as Executive Vice President and Chief Information Officer.
2022-06Matti Shem Tov served as an operating partner at Lone View Capital from June 2022 until March 2024.
2022-07Wendell Pritchett became a director.
2022-09Maroun Mourad was leader of the Claims Solutions division at Verisk Analytics Inc. from July 2022 to August 2025.
2022-10Andrew Snyder became Non-Executive Chair of the Board.
2022-10Anthony Munk's term as Lead Independent Director ended.
2022-12-31Fiscal year 2022 ended.
2023-01-01Fiscal year 2023 began.
2023-04Bar Veinstein joined Clarivate as President, Academia & Government.
2023-05Saurabh Saha became a director.
2023-05Henry Levy joined Clarivate as President, Life Sciences & Healthcare.
2023-10Adam T. Levyn became a director of Advantage Solutions, Inc.
2023-12-31Fiscal year 2023 ended.
2024-01-01Fiscal year 2024 began.
2024-02Wendell Pritchett became a director of 26North BDC, Inc.
2024-03-04Clarivate entered into an Investment Agreement with Exor N.V.
2024-05Suzanne Heywood became a director.
2024-08Matti Shem Tov became Chief Executive Officer of Clarivate.
2024-12-31Fiscal year 2024 ended.
2025-01-01Fiscal year 2025 began.
2025-01-18Company entered into a separation agreement with Melanie Margolin.
2025-02-28Melanie Margolin ceased to be an executive officer.
2025-03-21Melanie Margolin departed the Company.
2025-05-072025 Annual General Meeting of Shareholders held; Michael Angelakis retired from the Board.
2025-06Kenneth Cornick's term on the board of directors of CLEAR Secure, Inc. ended.
2025-06Kenneth Cornick's term on the board of directors of Center ID Corp. ended.
2025-06Kenneth Cornick's term on the board of trustees of LREI ended.
2025-07-22Kenneth Cornick was elected to the Board.
2025-07-25Company entered into a separation agreement with Gordon Samson.
2025-09-07Gordon Samson ceased to be an executive officer.
2025-09-08Maroun Mourad joined Clarivate as President, Intellectual Property.
2025-11Kenneth Cornick joined the board of Development Corporation for Israel.
2025-12-31Valeria Alberola resigned from the Board.
2025-12-31Gordon Samson departed the Company.
2025-12-31Fiscal year 2025 ended.
2026-01-01Share ownership guidelines compliance period began.
2026-01Saurabh Saha served as an advisor to Centessa Pharmaceuticals since January 2026.
2026-01Saurabh Saha's term as Chief Executive Officer of Centessa Pharmaceuticals ended.
2026-02-18Michael Easton and William Graff were settled certain performance share unit awards.
2026-03-03Michael Easton and William Graff filed late Form 4s for PSU settlements.
2026-03-16Record Date for the 2026 Annual General Meeting of Shareholders.
2026-03-23Company amended and restated its Executive Severance Plan.
2026-04-01Proxy Statement and 2025 Annual Report first distributed/made available to shareholders.
2026-04-01Date of the Board Chair's letter and General Counsel's notice.
2026-04-28Deadline for mailing proxy cards for the 2026 Annual General Meeting.
2026-05-11Deadline for General Counsel to receive written requests for admission tickets to the Annual Meeting.
2026-05-13Deadline for internet proxy voting and email proxy card submission (11:59 p.m. Eastern time).
2026-05-13Deadline for written notice of proxy revocation (1:00 p.m. BST).
2026-05-142026 Annual General Meeting of Shareholders.
2026-06-02Sublease with CIG for office space is active through this date, with annual renewals possible until March 31, 2029.
2026-12-02Deadline for shareholder proposals to be included in the 2027 proxy statement.
2027-01-14Earliest date for shareholder notice of proposals not included in the 2027 proxy statement.
2027-02-13Latest date for shareholder notice of proposals not included in the 2027 proxy statement.
2027-03-15Deadline for notice under SEC's universal proxy rule for director nominees.
2027Next annual general meeting of shareholders.

Recommendation

hold

While Clarivate PLC shows some positive operational momentum, such as accelerating ACV growth and a significant reduction in net loss, the overall financial picture for 2025 is mixed with declining revenues, adjusted profitability, and a substantial drop in market capitalization. The underperformance of long-term incentive awards (PSUs) against targets and the S&P 500 indicates challenges in achieving sustained growth and shareholder value creation. The company's strong governance and strategic focus on AI and subscription models are positive, but the financial results suggest a "hold" position until there is clearer evidence of consistent revenue growth and improved adjusted profitability.

Keywords

Clarivate, CLVT, proxy statement, annual general meeting, corporate governance, executive compensation, financial results, revenue, EBITDA, free cash flow, director re-election, auditor reappointment, intellectual property, life sciences, academia, government, AI, subscription model, shareholder value

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.